Ultima Genomics Major Sequencing Award for Singapore's National Precision Medicine (NPM) Program Phase III
Marks Ultima's first major win to support a national-scale clinical whole genome sequencing initiative NPM Phase III will leverage Ultima's UG200 Platform and recent advancements that enable large-scale applications, including Solaris 2.0 Chemistry, launched in February 2026. Ultima will...
Covered in this story
Call it yourself
No calls on $III yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Information Services Group Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.